
Director of System Laboratory Operations, HENRY FORD HEALTH SYSTEM
Member of the Healthcare Council
John Waugh is the Director of System Laboratory Operations at Henry Ford Health System, one of the top ten US laboratories in size. In this research and academic medical center in Detroit, Mr. Waugh has expertise in new and emerging clinical and molecular diagnostic systems, including products and services from Immucor, Cepheid, Osmetech, Beckman Coulter, Siemens, GenProbe/TEPNEL, Luminex, Quest, LabCorp, Sonic, Biorad, Abbott, Ortho, Olympus, Nanosphere, IVAX Diamedix, BD (GenOhm/TriPath), Hologic (Cytyc/Third Wave), Qiagen, Digene, Inverness (Biosite), Applied Biosystems, IRIS, Roche-Affymetrix, Ventana, Dako, Lab Vision, Sakura Finetek, Cardinal, Thermo Fisher, Sunquest, Sysmex, China Medical, Mindray, BioTest, Diasorin, DiaMed, Adaltis, & and Stago. He has experience in pathology, FDA/CLIA process, IPO evaluation, lab medicine, automation systems, electronic medical records (EMRs), group purchasing, blood products, information systems, middleware, lab regulation, & facility planning. (This is me - Update Profile)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
John Waugh has not published any GLG News Analyses.
| Study Group Name | No. Members |
|---|---|
| Luminex 100 System Users | 20 |
| Galileo Users | 17 |
| Economic Experts on Medical Devices (US) | 28 |
| Economic Experts on Managed Care | 716 |
June 26, 2008 | Palo Alto
GLG Seminar: Molecular Platforms and Laboratory Technology